Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/6/24 20:03 | 9/4/24 | APGE | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | S | -317 | 47.56 | 0 | -7 | -2 | 281 | D | ||||||||||||||
9/6/24 20:02 | 9/4/24 | APGE | Health | BioPrd | Biological Products, (No Diag | Henderson Michael Thomas | MA | DO | CEO | S | -1,905 | 47.62 | 0 | -40 | -3 | 1,394 | D | ||||||||||||||
8/23/24 20:05 | 8/23/24 | APGE | Health | BioPrd | Biological Products, (No Diag | Henderson Jane | MA | O | CFO | S | -290 | 48.26 | 0 | -6 | -3 | 201 | D | ||||||||||||||
8/9/24 20:05 | 8/7/24 | APGE | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | S | -298 | 40.67 | 0 | -7 | -2 | 287 | D | ||||||||||||||
8/9/24 20:05 | 8/7/24 | APGE | Health | BioPrd | Biological Products, (No Diag | Henderson Michael Thomas | MA | DO | CEO | S | -1,625 | 40.62 | 0 | -40 | -3 | 1,434 | D | ||||||||||||||
7/5/24 20:01 | 7/5/24 | APGE | Health | BioPrd | Biological Products, (No Diag | Henderson Michael Thomas | MA | DO | CEO | S | -559 | 37.26 | 0 | -15 | -1 | 1,474 | D | ||||||||||||||
7/5/24 20:01 | 7/3/24 | APGE | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | S | -225 | 37.60 | 0 | -6 | -2 | 295 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |